-
Je něco špatně v tomto záznamu ?
Infections caused by Candida spp. in surgical intensive care
František Vyhnánek, J. Vranková
Jazyk angličtina Země Česko
- MeSH
- amfotericin B farmakokinetika terapeutické užití MeSH
- antibakteriální látky terapeutické užití MeSH
- antifungální látky terapeutické užití MeSH
- Candida izolace a purifikace patogenita účinky léků MeSH
- chirurgie operační škodlivé účinky využití MeSH
- infekce dýchací soustavy farmakoterapie klasifikace komplikace MeSH
- infekce močového ústrojí farmakoterapie klasifikace komplikace MeSH
- infekce spojené se zdravotní péčí farmakoterapie komplikace MeSH
- infekce etiologie farmakoterapie komplikace MeSH
- jednotky intenzivní péče využití MeSH
- lidé MeSH
- mikrobiologické techniky metody využití MeSH
- péče o pacienty v kritickém stavu metody využití MeSH
- Check Tag
- lidé MeSH
Mycotic infections are lastly a significant morbidity and mortality cause of critically ill patients in surgical intensive care units. The most frequent causative agents of mycotic infections in surgical patients are Candida species. In order to assess the significance of mycotic infections for the critically ill in surgical intensive care and resuscitation units a retrospective evaluation of mycotic infection incidence and of their sensitivity to antimycotics has been performed, and some risk factors occurring in patients with fungal colonization have been determined. It was shown that colonization with yeasts, and candidaemia are most frequently caused by the fungus Candida albicans (88.2 - 93 %). Colonization with yeasts occurs most frequently in the air passages and the efferent urinary tract. The lowest resistance rate of Candida spp. was noted to Amphotericin B. Among the most frequent risk factors occurring in surgical patients with yeast colonization are risks from antibiotic treatment, and from certain interventional therapeutic procedures. In case of simultaneous occurrence of risk factors and proven yeast colonization, the route of choice is prophylactic, or pre-emptive therapy with an antimycotic (fluconazole, or Amphotericin B if resistance to the former has been proven).
VII. European congress of ESS, Prague, November 20.-22.
Bibliografie atd.Lit.: 10
- 000
- 00000naa 2200000 a 4500
- 001
- bmc07518229
- 003
- CZ-PrNML
- 005
- 20111210130427.0
- 008
- 090224s2003 xr e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Vyhnánek, František, $d 1944-2020 $7 nlk19990074033
- 245 10
- $a Infections caused by Candida spp. in surgical intensive care / $c František Vyhnánek, J. Vranková
- 314 __
- $a Department of Surgery, 3rd Faculty of Medicine, Charles University, Prague
- 500 __
- $a VII. European congress of ESS, Prague, November 20.-22.
- 504 __
- $a Lit.: 10
- 520 9_
- $a Mycotic infections are lastly a significant morbidity and mortality cause of critically ill patients in surgical intensive care units. The most frequent causative agents of mycotic infections in surgical patients are Candida species. In order to assess the significance of mycotic infections for the critically ill in surgical intensive care and resuscitation units a retrospective evaluation of mycotic infection incidence and of their sensitivity to antimycotics has been performed, and some risk factors occurring in patients with fungal colonization have been determined. It was shown that colonization with yeasts, and candidaemia are most frequently caused by the fungus Candida albicans (88.2 - 93 %). Colonization with yeasts occurs most frequently in the air passages and the efferent urinary tract. The lowest resistance rate of Candida spp. was noted to Amphotericin B. Among the most frequent risk factors occurring in surgical patients with yeast colonization are risks from antibiotic treatment, and from certain interventional therapeutic procedures. In case of simultaneous occurrence of risk factors and proven yeast colonization, the route of choice is prophylactic, or pre-emptive therapy with an antimycotic (fluconazole, or Amphotericin B if resistance to the former has been proven).
- 650 _2
- $a infekce $x etiologie $x farmakoterapie $x komplikace $7 D007239
- 650 _2
- $a chirurgie operační $x škodlivé účinky $x využití $7 D013514
- 650 _2
- $a infekce spojené se zdravotní péčí $x farmakoterapie $x komplikace $7 D003428
- 650 _2
- $a infekce dýchací soustavy $x farmakoterapie $x klasifikace $x komplikace $7 D012141
- 650 _2
- $a infekce močového ústrojí $x farmakoterapie $x klasifikace $x komplikace $7 D014552
- 650 _2
- $a jednotky intenzivní péče $x využití $7 D007362
- 650 _2
- $a péče o pacienty v kritickém stavu $x metody $x využití $7 D003422
- 650 _2
- $a Candida $x izolace a purifikace $x patogenita $x účinky léků $7 D002175
- 650 _2
- $a mikrobiologické techniky $x metody $x využití $7 D008828
- 650 _2
- $a antibakteriální látky $x terapeutické užití $7 D000900
- 650 _2
- $a amfotericin B $x farmakokinetika $x terapeutické užití $7 D000666
- 650 _2
- $a antifungální látky $x terapeutické užití $7 D000935
- 650 _2
- $a lidé $7 D006801
- 700 1_
- $a Vranková, J. $7 _AN028526
- 773 0_
- $w MED00010968 $t Bulletin HPB $g Roč. 11, č. 4 (2003), s. 156-159 $x 1210-6755
- 910 __
- $a ABA008 $b B 1845 $c 476 b $y 9
- 990 __
- $a 20090221132711 $b ABA008
- 991 __
- $a 20090226083815 $b ABA008
- 999 __
- $a ok $b bmc $g 636041 $s 488770
- BAS __
- $a 3
- BMC __
- $a 2003 $b 11 $c 4 $d 156-159 $i 1210-6755 $m Bulletin HPB $x MED00010968
- LZP __
- $a 2009-09/dkal